Eszter Sághy

Ms. Eszter Sághy


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in Value in Health Regional Issues
Verified
Journal Article
Open access
ESEszter Sághy
Eszter Sághy
DEDalma Erdősi
Dalma Erdősi
BNBertalan Németh
Bertalan Németh
SKSándor Kovács
Sándor Kovács
IWIstván Wittmann
István Wittmann
AZAntal Zemplényi
Antal Zemplényi
This study aimed to explore the association between demographic characteristics and patient-reported experiences (PREs) and patient-reported outcomes (PROs) in individuals living with diabetes, using the Swedish National Diabetes Register questionnaire. The study sought to understand how baseline attributes such as age, gender, and education affect patients' experiences and management of diabetes. We used a cross-sectional survey approach with 544 patients diagnosed as having type 1 or type 2 diabetes mellitus at the University of Pécs. An exploratory factor analysis was conducted to identify the key dimensions of diabetes-related experiences, followed by a confirmatory factor analysis to validate these dimensions. Regression analysis was used to examine the impact of demographic variables on the derived factors. The factor analysis revealed 5 key dimensions: diabetes-related obstacles, diabetes coping mechanisms, flexibility of healthcare providers, general well-being, and social support. Regression analysis indicated that older patients perceived fewer obstacles and demonstrated better coping mechanisms. Higher educational levels were significantly associated with greater satisfaction with healthcare provider flexibility. Females reported poorer overall well-being but better coping mechanisms than males. The findings suggest that demographic characteristics significantly influence patient experiences and outcomes in diabetes care. Tailored interventions that address specific demographic needs can enhance patient-centered care and improve management strategies. These insights underscore the importance of considering patient diversity in developing healthcare interventions and underscore the utility of the Swedish National Diabetes Register questionnaire in assessing diverse patient experiences in diabetes management.

4 February 2025 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
ESEszter Sághy
Eszter Sághy
MEMostafa Elsharkawy
Mostafa Elsharkawy
FMFrank Moriarty
Frank Moriarty
SKSándor Kovács
Sándor Kovács
IWIstván Wittmann
István Wittmann
ISIstv
Istv
Background: Chronic Kidney Disease (CKD) is a global health concern and is frequently underdiagnosed due to its subtle initial symptoms, contributing to increasing morbidity and mortality. A comprehensive understanding of CKD comorbidities could lead to the identification of risk-groups, more effective treatment and improved patient outcomes. Our research presents a two-fold objective: developing an effective machine learning (ML) workflow for text classification and entity relation extraction and assembling a broad list of diseases influencing CKD development and progression.Methods: We analysed 39,680 abstracts with CKD in the title from the Embase library. Abstracts about a disease affecting CKD development and/or progression were selected by multiple ML classifiers trained on a human-labelled sample. The best classifier was further trained with active learning. Disease names in question were extracted from the selected abstracts using a novel entity relation extraction methodology. The resulting disease list and their corresponding abstracts were manually checked and a final disease list was created.Findings: The SVM model gave the best results and was chosen for further training with active learning. This optimised ML workflow enabled us to discern 68 comorbidities across 15 ICD-10 disease groups contributing to CKD progression or development. The reading of the ML-selected abstracts showed that some diseases have direct causal effect on CKD, while others, like schizophrenia, has indirect causal effect on CKD.Interpretation: These findings have the potential to guide future CKD investigations, by facilitating the inclusion of a broader array of comorbidities in CKD prognostic models. Ultimately, our study enhances understanding of prognostic comorbidities and supports clinical practice by enabling improved patient monitoring, preventive strategies, and early detection for individuals at higher CKD development or progression risk.

Verified
Journal Article
Open access
PDF file
NFNóra Frank
Nóra Frank
CBCsilla Busa
Csilla Busa
ESEszter Sághy
Eszter Sághy
EPEva Pozsgai
Eva Pozsgai
CÁCsikós Ágnes
Csikós Ágnes
Background: Outpatient palliative care effectively alleviates symptom burden in advanced cancer patients, yet data from Central–Eastern Europe remain scarce. This retrospective study examined changes in revised Edmonton Symptom Assessment Scale (ESAS) scores from initial outpatient palliative consultation to first follow-up in Hungarian cancer patients, assessing clinically meaningful improvement and inter-symptom associations. Methods: Revised ESAS scores from 119 patients attending an outpatient palliative care clinic (2017–2020) were analyzed using paired baseline and first follow-up assessments (7–30 days). Symptom changes (Time 2–Time 1) were evaluated using Wilcoxon signed-rank tests. Clinically meaningful improvement was assessed with minimal clinically important difference thresholds (0.5× baseline SD). Sankey diagrams visualized symptom transitions, and multivariable linear regression examined inter-symptom associations. Results: Baseline pain was highest (mean 6.29, median 7), followed by fatigue, sleep disorder, and impaired well-being. At follow-up, significant reductions were observed in pain (mean 4.52, p = 0.001), nausea, dyspnea, constipation, sleep disorder, depression, and anxiety (all p < 0.05). Sankey diagrams showed shifts from severe to mild/moderate pain (50% to 24%) and constipation. Clinically meaningful improvement occurred in pain, nausea, and constipation, with 59–65% achieving ≥1-point pain reduction. Regression analyses showed that pain reduction was associated with concurrent improvements in sleep disorder (β = 0.31), depression (β = 0.20), fatigue (β = 0.20), and anxiety (β = 0.14), while dyspnea reduction was associated with concurrent improvements in depression (β = 0.22) and anxiety (β = 0.14). Conclusions: Outpatient palliative care in Hungarian cancer patients resulted in clinically meaningful symptom reductions, particularly pain and dyspnea. Improvements in these core symptoms were associated with concurrent improvements in other symptom domains, underscoring the clinical relevance of inter-symptom associations and supporting early, integrated outpatient palliative care and symptom cluster-based management.

25 July 2026 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
MHMirjana Huić
Mirjana Huić
DEDarija Erčević
Darija Erčević
ESEszter Sághy
Eszter Sághy
RGRenata Grenković
Renata Grenković
RHRomana Tandara Haček
Romana Tandara Haček
AZAntal T. Zemplényi
Antal T. Zemplényi
Background: Croatia has been implementing a Mobile multidisciplinary specialist palliative care team (MMSPCT), a home-based specialized palliative care service at the primary healthcare level since 2011. This study aimed to evaluate whether a MMSPCT performs better than usual care, in terms of health/well-being, experience with care, and cost outcomes. Methods: A 3-month prospective cohort study was performed during 2017–2019. Two cohorts were compared: MMSPCT vs. usual care cohort. Sample size was based on the literature data, ranging 150–200 patients per group. A SELFIE questionnaire with selected standardised instruments was used to assess health/well-being, experience with care, and cost (on four categories: drugs, medical devices, hospitalisation for acute and chronic care), at the beginning (T0), after 1 (T1), and after 3 months (T2). Propensity score weighting using subclassification method was used to reduce selection bias by grouping exposed and control group patients into four subclasses based on similar propensity scores. The average treatment effect on the treated (ATT) was estimated using linear models with propensity score weighing and clustering based on the subclasses of propensity scores. Cost outcome variables were analysed using hurdle models due to zero-inflation in the data. Results: 410 palliative care patients were included, 220 in MMSPCT and 190 in usual care cohort; 94 patients (42.7%) vs. 124 (65.3%) completed the study at 3-months follow-up. Baseline characteristics: age, gender and number of health conditions were balanced after propensity score weighting, but not living situation, education level, marital status and smoking. After 1 and 3 months, MMSPCT patients scored significantly better on person centeredness: 0.69 (3.83%) and 1.87 (10.39%) units higher score and compassionate care: 3.33 (2.78%) and 6.14 (5.12%) points more. After 3 months, they scored significantly better on physical (4.1 points more) and emotional functioning (5.18 points more) and had significantly lower measured healthcare costs. More MMSPCT patients died at their preferred place of death (48% vs. 23%). Conclusion: MMSPCT at primary care level may offer added value to palliative patients in Croatia and may result in a net saving in measured healthcare costs. Further clinical research is needed with a longer follow-up period and children’s cohorts.